Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Mylan and Novartis start selling generic Diovan
Yahoo/AP
Saturday, September 22, 2012 - 3:34pm
tags:
Mylan, Novartis, Diovan, generics
Dr. Reddy's Launches Generic Amoxil
Yahoo/Zacks
Saturday, September 22, 2012 - 3:33pm
tags:
Dr Reddy's, Amoxil, generics
5 Low-Debt Biotech Stocks Forecasted For Growth
Seeking Alpha
Saturday, September 22, 2012 - 2:24pm
tags:
Merrimack Pharmaceuticals, Durata Therapeutics, BioSpecifics Technologies, Pain Therapeutics, Acadia
ViroPharma up, FDA lifts ban
Yahoo/Investor's Business Daily
Saturday, September 22, 2012 - 2:22pm
tags:
Cinryze, angioedema
Healthcare Business Review: Questcor Defended, Watson’s Recall
Wall Street Cheat Street
Saturday, September 22, 2012 - 2:21pm
tags:
Questcor, Watson, product recalls
Science Arena Investors Need to Know
Motley Fool
Saturday, September 22, 2012 - 2:19pm
tags:
Arena, weight loss, obesity, Belviq
Vertex Pharmaceuticals: Today's Featured Health Care Winner
The Street
Saturday, September 22, 2012 - 2:18pm
tags:
Vertex Pharmaceuticals
Vivus Plunges on European Setback; Analysts React
Barron's
Saturday, September 22, 2012 - 2:18pm
tags:
Vivus, Qsymia
Why Halozyme Therapeutics Shares Soared
Motley Fool
Saturday, September 22, 2012 - 2:17pm
tags:
Halozyme
These 2 Stocks Stopped the Presses
Motley Fool
Saturday, September 22, 2012 - 2:16pm
tags:
Horizon Therapeutics, Savient
EU Approval? Fat Chance!
Motley Fool
Saturday, September 22, 2012 - 2:15pm
tags:
Vivus, obesity, weight loss, Qsymia
Report: Roche's Zelboraf, BMS' Yervoy control their segment
Fierce Pharma
Friday, September 21, 2012 - 1:13pm
tags:
Roche, Zelboraf, Bristol-Myers Squibb, Yervoy, melanoma
ViroPharma, Halozyme Rise After FDA Issue Cleared Up
Investors.com
Friday, September 21, 2012 - 1:11pm
tags:
Halozyme, FDA, ViroPharma, Cinryze, hereditary angiodema
Here We Go Again With AEterna Zentaris... Again
Seeking Alpha
Friday, September 21, 2012 - 1:07pm
tags:
Aeterna Zentaris, AEZS-130, perifosine, AEZS-108
EU body backs Novartis' Galvus, Eucreas for diabetes indications
Reuters
Friday, September 21, 2012 - 1:05pm
tags:
Europe, Novartis, Galvus, Eucreas, diabetes
Vivus Shares Feel The Pain: Blockbuster Diet Drug Likely Won't Be Sold In Europe
Forbes
Friday, September 21, 2012 - 1:00pm
tags:
Vivus, Europe, Qsiva, Qsymia, obesity
Generic-Drug Fee Plan at FDA Caught Up in Budget Impasse
Bloomberg
Friday, September 21, 2012 - 12:53pm
tags:
generics, FDA
Patent Licensure Positive, Removes Barrier To Potential SGYP Pharma Partnership
Yahoo/Reuters
Friday, September 21, 2012 - 12:43pm
tags:
patents, Synergy Pharmaceuticals, Ironwood, plecanatide
Astex stops developing possible cancer treatment
Yahoo/AP
Friday, September 21, 2012 - 12:03pm
tags:
Astex, lung cancer, amuvatinib
Apixaban (Eliquis) For Atrial Fibrillation Gets Positive European Recommendation
Forbes
Friday, September 21, 2012 - 11:52am
tags:
Apizaban, Eliquis, atrial fibrillation, Europe, Pfizer, Bristol-Myers Squibb

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.